Neurological Disorders

International Congress on Neuroimmunology and Therapeutics

DoubleTree by Hilton Hotel San Francisco Airport, San Francisco, CA, USA

Scientific Tracks Abstracts

• Endogenous pathways to limit inflammation in the CNS

  Denis Gris

  PDF HTML

• Modulation of neuroimmune interactions using nanotechnology to prevent the development of chronic pain

  E Alfonso Romero-Sandoval

  PDF HTML

• Role of complement classical pathway protein C1q in neuroinflammation and neurodegeneration

  Uday Kishore

  PDF HTML

• The therapeutic roles of ACE-overexpressing macrophages and resistance to structurally defined Aβ1-42 forms

  Maya Koronyo-Hamaoui, Altan Rentsendorj, Yosef Koronyo, Eric Y Hayden, Julia Sheyn, Dieu-Trang S Fuchs, Xiao Z Shen, Sebastien Fuchs, Kenneth E Bernstein, Keith L Black and David B Teplow

  PDF HTML

• Inhibition of system Xc- transporter attenuates autoimmune inflammatory demyelination

  Tara DeSilva

  PDF HTML

• The influence of glucocorticoids on the day/night changes of thymus-deriving natural regulatory T cells development and function

  Ewelina Kiernozek

  PDF HTML

• Pathophysiological roles of the prostaglandin D2 system in the central and peripheral nervous system

  Yoshihiro Urade

  PDF HTML

• Physiological stress results in potent suppression of iNKT cells following alpha-galactosylceramide mediated activation

  Christopher R. Shaler

  PDF HTML

• Physiological stress results in potent suppression of inkt cells following alpha-galactosylceramide mediated activation

  Chantana Boonyarat1,2, Pornthip Waiwut1, Chavi yenjai1, Jiranan Chotitumnavee1

  PDF HTML

• Gene expression changes consistent with neuro AIDS and impaired working memory in HIV-1 transgenic rats

  Pietro Paolo Sanna1, Vez Repunte-Canonigo1, Celine Lefebvre2, Olivier George1, Tomoya Kawamura1, Marisela Morales3, George F Koob1,4, Andrea Califano5 and Eliezer Masliah6

  PDF HTML

• Microglia polarization: A common paradigm spanning from neuro-oncology to infectious diseases

  Pierluigi Navarra, Lucia Lisi and Cinzia Dello Russo

  PDF HTML

• Vaccination with heat-shock protein-‘chaperoned’ α-synuclein as a novel immunotherapeutic strategy against parkinson’s disease

  Cintia Roodveldt

  PDF HTML

• Targeting the innate immune response to improve outcomes after CNS injury

  Juan Pablo de Rivero Vaccari

  PDF HTML

• The pathogenetic analysis of HPA axis regulated skin disorders-new inspiration on related drug development

  Jing Shang, Silin Pang, Qian Wang and Huali Wu

  PDF HTML

• CysLT and EP receptors as targets for anti-seizure drugs: Preclinical data

  Carlos Fernando Mello

  PDF HTML

• Neuroprotective role of curcumin and resveratrol combination against AlCl3 induced Alzheimer’s disease in rats

  Ahmad Bassiouny and Amira Zaky

  PDF HTML

• Neurometabolic evidences for diabetes and intermittent explosive disorder: A case report

  Ahmet Mithat Tavli, Burak Yulug, Tansel Cakir and Lütfü Hanoglu

  PDF HTML

• Glial receptors for extracellular mitochondrial transcription factor A (TFAM): Potential new therapeutic targets in the treatment of neurodegenerative diseases

  Stephanie M Schindler, Lindsay J Spielman, Svetlana Simtchouk, Jonathan P Little, Kirsten R Wolthers and Andis Klegeris

  PDF HTML

• Modulation of microglia-mediated neuroinflammation as a novel aspect of insulin activity in the central nervous system

  Lindsay J Spielman, Stephanie M Schindler, Douglas G Walker and Andis Klegeris

  PDF HTML

• FKBP12 and calcineurin matter: Repurposing FK506 to ameliorate synucleinopathies

  Gabriela Caraveo

  PDF HTML

• Impact of bone fracture on stroke recovery

  Hua Su

  PDF HTML

• Targeting soluble oligomers associated with Alzheimer with antibody-secreting mesenchymal stem cells

  Mourad Tayebi

  PDF HTML

• DA virus mutant H101 can alter t-cell mediated CNS pathogenesis through virus induced immunosuppression

  Robert S Fujinami

  PDF HTML

• Therapeutic Inflammatory Monocyte Modulation using MARCO-Targeting Carboxylated Immune- Modifying Nanoparticles for Amelioration of Neuroinflammatory Disease

  Stephen D. Miller

  PDF HTML

• Biomarker discovery for neuroendocrine cervical cancer

  Hong-Lin Chan1 and Hsiu-Chuan Chou2

  PDF HTML

• Behavioural signatures of neuroinflammation

  Denis Gris

  PDF HTML

• Circulating signatures in patients with parkinson’disease – a concrete search

  AJ Vanisree

  PDF HTML

• Conditioned PLB as a behavioral management strategy to manage asthma

  Matevz Leskovsek

  PDF HTML

• Initial presentation of multiple sclerosis in Northern Iran: Is there any comparison to other countries?

  Seyed Masoud Hojati, Amin Zarghami and Ali Bijani

  PDF HTML